| Literature DB >> 22768270 |
Predrag Kalajdzic1, Stefan Oehler, Martin Reczko, Nena Pavlidi, John Vontas, Artemis G Hatzigeorgiou, Charalambos Savakis.
Abstract
Insecticide resistance is a worldwide problem with major impact on agriculture and human health. Understanding the underlying molecular mechanisms is crucial for the management of the phenomenon; however, this information often comes late with respect to the implementation of efficient counter-measures, particularly in the case of metabolism-based resistance mechanisms. We employed a genome-wide insertional mutagenesis screen to Drosophila melanogaster, using a Minos-based construct, and retrieved a line (MiT[w(-)]3R2) resistant to the neonicotinoid insecticide Imidacloprid. Biochemical and bioassay data indicated that resistance was due to increased P450 detoxification. Deep sequencing transcriptomic analysis revealed substantial over- and under-representation of 357 transcripts in the resistant line, including statistically significant changes in mixed function oxidases, peptidases and cuticular proteins. Three P450 genes (Cyp4p2, Cyp6a2 and Cyp6g1) located on the 2R chromosome, are highly up-regulated in mutant flies compared to susceptible Drosophila. One of them (Cyp6g1) has been already described as a major factor for Imidacloprid resistance, which validated the approach. Elevated expression of the Cyp4p2 was not previously documented in Drosophila lines resistant to neonicotinoids. In silico analysis using the Drosophila reference genome failed to detect transcription binding factors or microRNAs associated with the over-expressed Cyp genes. The resistant line did not contain a Minos insertion in its chromosomes, suggesting a hit-and-run event, i.e. an insertion of the transposable element, followed by an excision which caused the mutation. Genetic mapping placed the resistance locus to the right arm of the second chromosome, within a ∼1 Mb region, where the highly up-regulated Cyp6g1 gene is located. The nature of the unknown mutation that causes resistance is discussed on the basis of these results.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22768270 PMCID: PMC3386967 DOI: 10.1371/journal.pone.0040296
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
LC50s for Imidacloprid and DDT of susceptible and resistant flies.
| IMIDACLOPRID | DDT | |||
| LC50 µg/ml (95% confidence limits) | RR | LC50 µg/vial (95% confidence limits) | RR | |
| iso31 | 0.18 (0.15–0.21) | - | 0.37 (0.15–0.65) | - |
| MiT[ | 3.30 (1.90–4.10) | 18 | 37.50 (32.20–41.90) | 100 |
RR (resistance ratio) – LC50 value of the MiT[w]3R2 line/LC50 value of the iso31 line.
Activities of detoxification enzymes of resistant and susceptible lines.
| Cytochrome P450 monooxygenase (alive larvae) (pg/min/larvae) ± SD | Esterase (nmol a-naphthol produced/min/mg) ± SD | Esterase (nmol b naphthol produced/min/mg) ± SD | GST (μmole/min/mg) ± SD | |
| MiT[ | 2.1±0.1 | 73±2 | 27±2 | 0.13±0.04 |
| iso31 | 0.72±0.05 | 54±4 | 31±4 | 0.12±0.04 |
| Fold difference MiT[ | 3.0 | 1.4 | 0.8 | 1.0 |
Gene functional groups in the up-regulated genes (analyzed with the DAVID 6.7 BETA bioinformatics resource).
| Peptidase activity, proteolysis | Cytochrome P450 (Cyp) genes | Metallocarboxypeptidase activity, biopolymer catabolic process, macromolecule catabolic process | |||
| Enrichment Score: 5.10 | Enrichment Score: 3.73 | Enrichment Score: 2.32 | |||
| Gene name | Kappa | Gene name | Kappa | Gene name | Kappa |
| CG31219 | 1.00 | Cyp309a2 | 0.99 | CG8539 | 0.89 |
| Jonah 65Ai | 1.00 | Cyp6w1 | 0.99 | CG8560 | 0.84 |
| CG10469 | 1.00 | Cyp4p2 | 0.96 | CG15254 | 0.65 |
| CG9676 | 1.00 | Cyp6g2 | 0.96 | CG2493 | 0.62 |
| CG7829 | 0.97 | Cyp4d14 | 0.94 | CG31918 | 0.59 |
| Jonah 25Biii | 0.97 | Cyp4e3 | 0.93 | ||
| CG32277 | 0.97 | Cyp6g1 | 0.87 | ||
| CG4259 | 0.97 | Cyp6a2 | 0.84 | ||
| Jonah 74E | 0.94 | ||||
| CG10477 | 0.94 | ||||
| Jonah 25Bii | 0.91 | ||||
| CG11911 | 0.91 | ||||
| CG4812 | 0.91 | ||||
| Jonah 25Bi | 0.84 | ||||
| CG31918 | 0.59 | ||||
| CG2493 | 0.56 | ||||
Kappa score – The Kappa value quantitatively measures the degree to which genes share similar annotation terms (the higher the Kappa, the stronger the functional similarity).
Gene functional groups in the down-regulated genes (analyzed with DAVID 6.7 BETA bioinformatics resource).
| Structural constituent of chitin-based cuticle | Peptidase activity, proteolysis | ||
| Enrichment Score: 2.52 | Enrichment Score: 1.05 | ||
| Gene name | Kappa | Gene name | Kappa |
| CG1252 | 1.00 | CG17234 | 1.00 |
| CG2360 | 1.00 | CG18180 | 0.97 |
| CG2341 | 1.00 | CG18179 | 0.97 |
| Cuticular protein 56F | 0.91 | CG11037 | 0.94 |
| Cuticular protein 47Ef | 0.83 | Jonah 66Ci | 0.94 |
| Serine protease 12 | 0.88 | ||
| CG34043 | 0.80 | ||
Kappa score – The Kappa value quantitatively measures the degree to which genes share similar annotation terms (the higher the Kappa, the stronger the functional similarity).
Functional annotation clusters in the up-regulated genes (analyzed with the DAVID 6.7 BETA bioinformatics resource).
| No. clusters 10 | |||||||
| Annotation Cluster 1 | Enrichment Score: 5.62 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_MF_ALL | GO:0008236∼serine-type peptidase activity | 2.92E-006 | Jon25Bi, CG31219, CG11911, CG4259, Jon25Biii, Jon25Bii, CG2493, Ser8, CG10477, Jon65Ai, CG10469, Jon74E, CG7829, CG9676, CG32277, CG31219 | 4.69 | 5.81E-004 | 2.91E-004 | 3.66E-003 |
| GOTERM_MF_ALL | GO:0017171∼serine hydrolase activity | 3.15E-006 | Jon25Bi, CG31219, CG11911, CG4259, Jon25Biii, Jon25Bii, CG2493, Ser8, CG10477, Jon65Ai, CG10469, Jon74E, CG7829, CG9676, CG32277, CG31219 | 4.66 | 6.27E-004 | 2.09E-004 | 3.95E-003 |
| Annotation Cluster 2 | Enrichment Score: 4.98 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_ALL | GO:0006508∼proteolysis | 2.13E-005 | Jon25Bi, CG31219, CG11911, CG4259, Jon25Biii, Jon25Bii, CG31918, CG15254, CG2493, skpB, Ser8, CG10477, Jon65Ai, CG10469, CG8560, CG8539, Jon74E, CG7829, CG31704, CG9676, CG32277, CG31219 | 2.87 | 1.09E-002 | 1.09E-002 | 3.08E-002 |
| GOTERM_BP_ALL | GO:0030163∼protein catabolic process | 2.45E-005 | Jon25Bi, CG31219, CG11911, CG4259, Jon25Biii, Jon25Bii, CG31918, CG15254, CG2493, skpB, Ser8, CG10477, Jon65Ai, CG10469, CG8560, CG8539, Jon74E, CG7829, CG31704, CG9676, CG32277, CG31219 | 2.84 | 1.26E-002 | 6.30E-003 | 3.54E-002 |
| Annotation Cluster 3 | Enrichment Score: 4.69 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_ALL | GO:0043285∼biopolymer catabolic process | 3.04E-005 | Jon25Bi, CG31219, Ercc1, CG11911, CG4259, Jon25Biii, Jon25Bii, CG31918, CG15254, CG2493, skpB, Ser8, CG10477, Jon65Ai, CG10469, CG8560, CG8539, Jon74E, CG7829, CG31704, CG9676, CG32277, CG31219 | 2.70 | 1.56E-002 | 5.21E-003 | 4.39E-002 |
| GOTERM_BP_ALL | GO:0009057∼macromolecule catabolic process | 6.93E-005 | Jon25Bi, CG31219, Ercc1, CG11911, CG4259, Jon25Biii, Jon25Bii, CG31918, CG15254, CG2493, skpB, Ser8, CG10477, Jon65Ai, CG10469, CG8560, CG8539, Jon74E, CG7829, CG31704, CG9676, CG32277, CG31219 | 2.55 | 3.51E-002 | 7.13E-003 | 1.00E-001 |
| Annotation Cluster 4 | Enrichment Score: 4.23 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_MF_ALL | GO:0070011∼peptidase activity, acting on L-amino acid peptides | 5.34E-005 | Jon25Bi, CG31219, CG11911, CG4259, Jon25Biii, Jon25Bii, CG31918, CG15254, CG2493, Ser8, CG10477, Jon65Ai, CG10469, CG8560, CG8539, Jon74E, CG7829, CG9676, CG32277, CG31219 | 2.95 | 1.06E-002 | 1.77E-003 | 6.69E-002 |
| GOTERM_MF_ALL | GO:0008233∼peptidase activity | 1.10E-004 | Jon25Bi, CG31219, CG11911, CG4259, Jon25Biii, Jon25Bii, CG31918, CG15254, CG2493, Ser8, CG10477, Jon65Ai, CG10469, CG8560, CG8539, Jon74E, CG7829, CG9676, CG32277, CG31219 | 2.79 | 2.21E-002 | 2.23E-003 | 1.41E-001 |
| Annotation Cluster 5 | Enrichment Score: 4.12 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_MF_ALL | GO:0046906∼tetrapyrrole binding | 8.58E-005 | Cyp4e3, Cyp6a2, Cyp309a2, Cyp6w1, Cyp4p2, Cyp6g1, Cyp6g2, CG4009, Cyp4d14 | 6.26 | 1.69E-002 | 1.90E-003 | 1.07E-001 |
| GOTERM_MF_ALL | GO:0020037∼heme binding | 8.58E-005 | Cyp4e3, Cyp6a2, Cyp309a2, Cyp6w1, Cyp4p2, Cyp6g1, Cyp6g2, CG4009, Cyp4d14 | 6.26 | 1.69E-002 | 1.90E-003 | 1.07E-001 |
| Annotation Cluster 6 | Enrichment Score: 3.04 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_ALL | GO:0000070∼mitotic sister chromatid segregation | 1.04E-003 | rod, cid, Kmn1, Nuf2, Spc25 | 10.93 | 4.14E-001 | 4.75E-002 | 1.49E+000 |
| GOTERM_BP_ALL | GO:0000819∼sister chromatid segregation | 1.12E-003 | rod, cid, Kmn1, Nuf2, Spc25 | 10.69 | 4.40E-001 | 4.72E-002 | 1.61E+000 |
| Annotation Cluster 7 | Enrichment Score: 2.99 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_ALL | GO:0055114∼oxidation reduction | 9.79E-004 | CG31809, Cyp4e3, Cyp6a2, ry, Cp7Fb, CG11162, Cyp309a2, Cyp6w1, Cyp4p2, Cyp6g1, Cyp6g2, CG5235, CG4009, Fad2, Cyp4d14, CG31810 | 2.58 | 3.97E-001 | 5.46E-002 | 1.41E+000 |
| GOTERM_MF_ALL | GO:0016491∼oxidoreductase activity | 3.13E-003 | CG31809, Cyp4e3, Cyp6a2, ry, Cp7Fb, CG11162, Cyp309a2, Cyp6w1, Cyp4p2, Cyp6g1, Cyp6g2, CG5235, CG4009, Fad2, Cyp4d14, CG31810 | 2.32 | 4.65E-001 | 5.07E-002 | 3.86E+000 |
| Annotation Cluster 8 | Enrichment Score: 2.88 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_MF_ALL | GO:0009055∼electron carrier activity | 1.18E-003 | Cyp4e3, Cyp6a2, ry, Cyp309a2, Cyp6w1, Cyp4p2, Cyp6g1, Cyp6g2, Cyp4d14 | 4.25 | 2.09E-001 | 2.11E-002 | 1.47E+000 |
| Annotation Cluster 9 | Enrichment Score: 2.79 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_ALL | GO:0051310∼metaphase plate congression | 3.83E-004 | cid, Kmn1, Nuf2, Spc25 | 26.81 | 1.79E-001 | 2.78E-002 | 5.53E-001 |
| GOTERM_BP_ALL | GO:0050000∼chromosome localization | 4.68E-004 | cid, Kmn1, Nuf2, Spc25 | 25.14 | 2.15E-001 | 2.97E-002 | 6.75E-001 |
| GOTERM_BP_ALL | GO:0051303∼establishment of chromosome localization | 4.68E-004 | cid, Kmn1, Nuf2, Spc25 | 25.14 | 2.15E-001 | 2.97E-002 | 6.75E-001 |
| GOTERM_BP_ALL | GO:0051656∼establishment of organelle localization | 3.73E-002 | cid, Kmn1, Nuf2, Spc25 | 5.36 | 1.00E+000 | 5.74E-001 | 4.23E+001 |
| GOTERM_BP_ALL | GO:0051640∼organelle localization | 4.80E-002 | cid, Kmn1, Nuf2, Spc25 | 4.85 | 1.00E+000 | 6.53E-001 | 5.09E+001 |
| Annotation Cluster 10 | Enrichment Score: 2.17 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_ALL | GO:0007067∼mitosis | 3.73E-003 | rod, Klp61F, Mcm2, cid, Kmn1, Nuf2, Spc25 | 4.63 | 8.55E-001 | 1.38E-001 | 5.27E+000 |
| GOTERM_BP_ALL | GO:0000280∼nuclear division | 3.98E-003 | rod, Klp61F, Mcm2, cid, Kmn1, Nuf2, Spc25 | 4.57 | 8.72E-001 | 1.37E-001 | 5.61E+000 |
| GOTERM_BP_ALL | GO:0000087∼M phase of mitotic cell cycle | 3.98E-003 | rod, Klp61F, Mcm2, cid, Kmn1, Nuf2, Spc25 | 4.57 | 8.72E-001 | 1.37E-001 | 5.61E+000 |
| GOTERM_BP_ALL | GO:0048285∼organelle fission | 4.65E-003 | rod, Klp61F, Mcm2, cid, Kmn1, Nuf2, Spc25 | 4.43 | 9.10E-001 | 1.48E-001 | 6.52E+000 |
Functional annotation clusters in the down-regulated genes (analyzed with the DAVID 6.7 BETA bioinformatics resource).
| No clusters 13 | |||||||
| Annotation Cluster 1 | Enrichment Score: 4.44 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_MF_FAT | GO:0045735∼nutrient reservoir activity | 2.68E-005 | Lsp1beta, Lsp1alpha, Lsp1gamma, CG11345 | 58.67 | 6.14E-003 | 6.14E-003 | 3.43E-002 |
| GOTERM_MF_ALL | GO:0045735∼nutrient reservoir activity | 3.21E-005 | Lsp1beta, Lsp1alpha, Lsp1gamma, CG11345 | 55.50 | 8.99E-003 | 8.99E-003 | 4.25E-002 |
| GOTERM_MF_1 | GO:0045735∼nutrient reservoir activity | 5.48E-005 | Lsp1beta, Lsp1alpha, Lsp1gamma, CG11345 | 47.84 | 5.48E-004 | 5.48E-004 | 3.29E-002 |
| Annotation Cluster 2 | Enrichment Score: 3.66 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_FAT | GO:0006026∼aminoglycan catabolic process | 1.78E-004 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, Cht9 | 17.16 | 8.50E-002 | 4.34E-002 | 2.55E-001 |
| GOTERM_BP_FAT | GO:0000272∼polysaccharide catabolic process | 2.01E-004 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, Cht9 | 16.65 | 9.55E-002 | 3.29E-002 | 2.89E-001 |
| GOTERM_BP_ALL | GO:0006026∼aminoglycan catabolic process | 2.42E-004 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, Cht9 | 15.89 | 1.39E-001 | 1.39E-001 | 3.59E-001 |
| GOTERM_BP_ALL | GO:0000272∼polysaccharide catabolic process | 2.74E-004 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, Cht9 | 15.41 | 1.56E-001 | 8.13E-002 | 4.05E-001 |
| Annotation Cluster 3 | Enrichment Score: 2.68 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_MF_FAT | GO:0005214∼structural constituent of chitin-based cuticle | 1.43E-003 | Cpr49Ag, Cpr50Cb, Cpr56F, Ccp84Ad, Ccp84Ab, Ccp84Aa | 5.60 | 2.81E-001 | 1.04E-001 | 1.82E+000 |
| GOTERM_MF_ALL | GO:0005214∼structural constituent of chitin-based cuticle | 1.97E-003 | Cpr49Ag, Cpr50Cb, Cpr56F, Ccp84Ad, Ccp84Ab, Ccp84Aa | 5.29 | 4.26E-001 | 1.69E-001 | 2.58E+000 |
| GOTERM_MF_FAT | GO:0042302∼structural constituent of cuticle | 2.23E-003 | Cpr49Ag, Cpr50Cb, Cpr56F, Ccp84Ad, Ccp84Ab, Ccp84Aa | 5.13 | 4.02E-001 | 1.21E-001 | 2.82E+000 |
| GOTERM_MF_ALL | GO:0042302∼structural constituent of cuticle | 3.06E-003 | Cpr49Ag, Cpr50Cb, Cpr56F, Ccp84Ad, Ccp84Ab, Ccp84Aa | 4.86 | 5.77E-001 | 1.94E-001 | 3.97E+000 |
| Annotation Cluster 4 | Enrichment Score: 2.59 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_FAT | GO:0006022∼aminoglycan metabolic process | 1.72E-003 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, Cht9, CG7298, CG31077 | 5.38 | 5.77E-001 | 1.58E-001 | 2.45E+000 |
| GOTERM_BP_FAT | GO:0005976∼polysaccharide metabolic process | 2.50E-003 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, Cht9, CG7298, CG31077 | 4.99 | 7.14E-001 | 1.64E-001 | 3.54E+000 |
| GOTERM_BP_ALL | GO:0006022∼aminoglycan metabolic process | 2.60E-003 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, Cht9, CG7298, CG31077 | 4.98 | 8.01E-001 | 1.64E-001 | 3.79E+000 |
| GOTERM_BP_ALL | GO:0005976∼polysaccharide metabolic process | 3.75E-003 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, Cht9, CG7298, CG31077 | 4.62 | 9.03E-001 | 2.08E-001 | 5.43E+000 |
| Annotation Cluster 5 | Enrichment Score: 2.49 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_FAT | GO:0009617∼response to bacterium | 8.09E-004 | Dpt, AttC, Dro, DptB, TM9SF4, PGRP-SC1a, PGRP-SC1b | 8.04 | 3.33E-001 | 9.62E-002 | 1.16E+000 |
| GOTERM_BP_ALL | GO:0009617∼response to bacterium | 1.17E-003 | Dpt, AttC, Dro, DptB, TM9SF4, PGRP-SC1a, PGRP-SC1b | 7.44 | 5.15E-001 | 1.65E-001 | 1.71E+000 |
| GOTERM_BP_ALL | GO:0051707∼response to other organism | 9.06E-003 | Dpt, AttC, Dro, DptB, TM9SF4, PGRP-SC1a, PGRP-SC1b | 4.62 | 9.96E-001 | 3.32E-001 | 1.26E+001 |
| GOTERM_BP_ALL | GO:0009607∼response to biotic stimulus | 1.22E-002 | Dpt, AttC, Dro, DptB, TM9SF4, PGRP-SC1a, PGRP-SC1b | 4.29 | 9.99E-001 | 3.78E-001 | 1.66E+001 |
| Annotation Cluster 6 | Enrichment Score: 2.40 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_MF_FAT | GO:0005344∼oxygen transporter activity | 7.66E-003 | Lsp1beta, Lsp1alpha, Lsp1gamma | 22.00 | 8.29E-001 | 2.98E-001 | 9.39E+000 |
| GOTERM_MF_ALL | GO:0005344∼oxygen transporter activity | 8.59E-003 | Lsp1beta, Lsp1alpha, Lsp1gamma | 20.81 | 9.12E-001 | 3.84E-001 | 1.08E+001 |
| Annotation Cluster 7 | Enrichment Score: 2.11 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_FAT | GO:0045087∼innate immune response | 9.92E-003 | Dpt, AttC, Dro, PGRP-SC1a, PGRP-SC1b, PGRP-SC2 | 5.84 | 9.93E-001 | 3.19E-001 | 1.34E+001 |
| GOTERM_BP_ALL | GO:0045087∼innate immune response | 1.30E-002 | Dpt, AttC, Dro, PGRP-SC1a, PGRP-SC1b, PGRP-SC2 | 5.41 | 1.00E+000 | 3.64E-001 | 1.77E+001 |
| Annotation Cluster 8 | Enrichment Score: 1.99 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_FAT | GO:0006955∼immune response | 4.33E-003 | Dpt, AttC, Dro, DptB, TM9SF4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2 | 4.47 | 8.86E-001 | 1.95E-001 | 6.05E+000 |
| GOTERM_BP_ALL | GO:0006955∼immune response | 6.41E-003 | Dpt, AttC, Dro, DptB, TM9SF4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2 | 4.14 | 9.82E-001 | 2.83E-001 | 9.11E+000 |
| GOTERM_BP_ALL | GO:0002376∼immune system process | 1.95E-002 | Dpt, AttC, Dro, DptB, TM9SF4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2 | 3.25 | 1.00E+000 | 4.40E-001 | 2.53E+001 |
| GOTERM_BP_1 | GO:0002376∼immune system process | 2.09E-002 | Dpt, AttC, Dro, DptB, TM9SF4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2 | 3.19 | 3.59E-001 | 1.99E-001 | 1.51E+001 |
| Annotation Cluster 9 | Enrichment Score: 1.88 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_FAT | GO:0019731∼antibacterial humoral response | 1.74E-003 | Dpt, AttC, Dro, DptB | 16.28 | 5.81E-001 | 1.35E-001 | 2.47E+000 |
| GOTERM_BP_ALL | GO:0019731∼antibacterial humoral response | 2.19E-003 | Dpt, AttC, Dro, DptB | 15.07 | 7.43E-001 | 1.76E-001 | 3.19E+000 |
| GOTERM_BP_FAT | GO:0019730∼antimicrobial humoral response | 2.47E-002 | Dpt, AttC, Dro, DptB | 6.28 | 1.00E+000 | 5.43E-001 | 3.03E+001 |
| GOTERM_BP_ALL | GO:0019730∼antimicrobial humoral response | 3.04E-002 | Dpt, AttC, Dro, DptB | 5.81 | 1.00E+000 | 5.49E-001 | 3.67E+001 |
| GOTERM_BP_FAT | GO:0006959∼humoral immune response | 3.83E-002 | Dpt, AttC, Dro, DptB | 5.29 | 1.00E+000 | 6.62E-001 | 4.30E+001 |
| GOTERM_BP_ALL | GO:0006959∼humoral immune response | 4.66E-002 | Dpt, AttC, Dro, DptB | 4.90 | 1.00E+000 | 6.80E-001 | 5.08E+001 |
| Annotation Cluster 10 | Enrichment Score: 1.83 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_MF_FAT | GO:0030247∼polysaccharide binding | 1.31E-002 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, CG7298, CG31077 | 4.22 | 9.52E-001 | 3.96E-001 | 1.55E+001 |
| GOTERM_MF_FAT | GO:0001871∼pattern binding | 1.31E-002 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, CG7298, CG31077 | 4.22 | 9.52E-001 | 3.96E-001 | 1.55E+001 |
| GOTERM_MF_ALL | GO:0001871∼pattern binding | 1.67E-002 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, CG7298, CG31077 | 3.99 | 9.91E-001 | 5.45E-001 | 2.00E+001 |
| GOTERM_MF_ALL | GO:0030247∼polysaccharide binding | 1.67E-002 | Cht4, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, Cht8, CG7298, CG31077 | 3.99 | 9.91E-001 | 5.45E-001 | 2.00E+001 |
| Annotation Cluster 11 | Enrichment Score: 1.81 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_FAT | GO:0006032∼chitin catabolic process | 1.11E-002 | Cht4, Cht8, Cht9 | 18.31 | 9.96E-001 | 3.28E-001 | 1.48E+001 |
| GOTERM_BP_ALL | GO:0006032∼chitin catabolic process | 1.29E-002 | Cht4, Cht8, Cht9 | 16.95 | 1.00E+000 | 3.77E-001 | 1.75E+001 |
| GOTERM_MF_FAT | GO:0004568∼chitinase activity | 1.89E-002 | Cht4, Cht8, Cht9 | 13.89 | 9.87E-001 | 4.65E-001 | 2.17E+001 |
| GOTERM_MF_ALL | GO:0004568∼chitinase activity | 2.11E-002 | Cht4, Cht8, Cht9 | 13.15 | 9.97E-001 | 5.75E-001 | 2.46E+001 |
| Annotation Cluster 12 | Enrichment Score: 1.53 | ||||||
| Category | Term | PValue | Genes | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_BP_FAT | GO:0055114∼oxidation reduction | 8.91E-003 | Nos, CG14946, Gld, Cyp9b1, Prx2540-2, Cyp4p1, CG32557, CG6762, Cyp4d21, CG18231, CG17843, CG30093, Eip71CD | 2.29 | 9.89E-001 | 3.11E-001 | 1.21E+001 |
| GOTERM_BP_ALL | GO:0055114∼oxidation reduction | 1.67E-002 | Nos, CG14946, Gld, Cyp9b1, Prx2540-2, Cyp4p1, CG32557, CG6762, Cyp4d21, CG18231, CG17843, CG30093, Eip71CD | 2.12 | 1.00E+000 | 4.06E-001 | 2.21E+001 |
| Annotation Cluster 13 | Enrichment Score: 1.48 | ||||||
| Category | Term | PValue | Gene name | Fold Enrichment | Bonferroni | Benjamini | FDR |
| GOTERM_MF_ALL | GO:0004553∼hydrolase activity, hydrolyzing O-glycosyl compounds | 3.34E-002 | Cht4, Mal-B1, Mal-A7, Cht8, Cht9 | 4.08 | 1.00E+000 | 6.53E-001 | 3.62E+001 |
| GOTERM_MF_ALL | GO:0016798∼hydrolase activity, acting on glycosyl bonds | 4.58E-002 | Cht4, Mal-B1, Mal-A7, Cht8, Cht9 | 3.68 | 1.00E+000 | 6.98E-001 | 4.62E+001 |
Figure 1Mapping of the lethality and resistance loci on the right arm of the second chromosome in the resistant line MiT[w]3R2.
The resistance locus was mapped relative to P element insertions to a region between 8 Mb and 8.5 Mb (black arrows on the second scale, distance between insertion and resistance region is indicated with dotted horizontal lines). The location of the three highly expressed P450 genes (Cyp6a2, Cyp6g1 and Cyp4p2) in the resistant MiT[w]3R2 line is indicated. Below is a comparison of single nucleotide polymorphism (SNP) density (per 1 Kb) between resistant line MiT[w]3R2 and susceptible line iso31. At the bottom, Bloomington deletions overlapping lethality locus (filled box) and flanking the lethality locus (open boxes) (lethality maps to the region between 8.5 Mb and 9.9 Mb, close to the place of recombination).
Figure 2Crossing scheme of the genome-wide insertional mutagenesis system.
TREP 2.30 – promoter delivery, minimal promoter under tTA control, w marker CyO [MiT 2.4] – Minos transposase source, CyO marker Sco – Sco marker BOEtTA – tTA source, egfp marker.